Citigroup Inc. Decreases Holdings in Evolent Health Inc (EVH)

Share on StockTwits

Citigroup Inc. trimmed its position in shares of Evolent Health Inc (NYSE:EVH) by 7.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 80,881 shares of the technology company’s stock after selling 6,442 shares during the period. Citigroup Inc. owned approximately 0.10% of Evolent Health worth $1,614,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the business. Parkside Financial Bank & Trust lifted its stake in Evolent Health by 57.7% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,628 shares of the technology company’s stock worth $72,000 after purchasing an additional 1,327 shares in the last quarter. State Board of Administration of Florida Retirement System raised its stake in shares of Evolent Health by 7.6% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 24,749 shares of the technology company’s stock valued at $494,000 after acquiring an additional 1,758 shares in the last quarter. US Bancorp DE raised its stake in shares of Evolent Health by 6.1% in the third quarter. US Bancorp DE now owns 40,225 shares of the technology company’s stock valued at $1,142,000 after acquiring an additional 2,301 shares in the last quarter. Pier 88 Investment Partners LLC raised its stake in shares of Evolent Health by 10.2% in the fourth quarter. Pier 88 Investment Partners LLC now owns 24,930 shares of the technology company’s stock valued at $497,000 after acquiring an additional 2,315 shares in the last quarter. Finally, FDx Advisors Inc. raised its stake in shares of Evolent Health by 21.9% in the third quarter. FDx Advisors Inc. now owns 14,936 shares of the technology company’s stock valued at $424,000 after acquiring an additional 2,682 shares in the last quarter.

Shares of NYSE EVH opened at $13.01 on Friday. Evolent Health Inc has a 12-month low of $12.09 and a 12-month high of $29.05. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.81 and a current ratio of 1.81. The firm has a market capitalization of $1.08 billion, a PE ratio of -37.17 and a beta of 1.25.

Evolent Health (NYSE:EVH) last posted its quarterly earnings results on Tuesday, February 26th. The technology company reported ($0.07) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.04) by ($0.03). Evolent Health had a negative net margin of 8.40% and a negative return on equity of 2.39%. The business had revenue of $193.10 million during the quarter, compared to analyst estimates of $188.66 million. During the same quarter in the prior year, the business earned ($0.04) earnings per share. The firm’s quarterly revenue was up 69.8% on a year-over-year basis. As a group, analysts anticipate that Evolent Health Inc will post -0.68 earnings per share for the current year.

Several analysts have recently issued reports on the company. ValuEngine cut Evolent Health from a “buy” rating to a “hold” rating in a research note on Tuesday, January 29th. Zacks Investment Research cut Evolent Health from a “hold” rating to a “sell” rating in a research note on Wednesday. Oppenheimer reduced their price objective on Evolent Health from $31.00 to $21.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 27th. Cantor Fitzgerald reduced their price objective on Evolent Health from $37.00 to $20.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 27th. Finally, Wells Fargo & Co reduced their price objective on Evolent Health from $34.00 to $21.50 and set an “outperform” rating on the stock in a research note on Wednesday, February 27th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and twelve have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $26.54.

ILLEGAL ACTIVITY NOTICE: “Citigroup Inc. Decreases Holdings in Evolent Health Inc (EVH)” was reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at https://www.tickerreport.com/banking-finance/4222555/citigroup-inc-decreases-holdings-in-evolent-health-inc-evh.html.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management.

Recommended Story: Stock Split

Institutional Ownership by Quarter for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

EthereumX Price Hits $0.0010 on Top Exchanges
EthereumX Price Hits $0.0010 on Top Exchanges
$727.15 Million in Sales Expected for Carter’s, Inc.  This Quarter
$727.15 Million in Sales Expected for Carter’s, Inc. This Quarter
Nordson  Posts  Earnings Results, Misses Expectations By $0.06 EPS
Nordson Posts Earnings Results, Misses Expectations By $0.06 EPS
LGL Group Inc  CEO Michael J. Ferrantino Sells 10,100 Shares
LGL Group Inc CEO Michael J. Ferrantino Sells 10,100 Shares
Snap Inc  CAO Sells $11,998.47 in Stock
Snap Inc CAO Sells $11,998.47 in Stock
Evolus  PT Set at $31.00 by Mizuho
Evolus PT Set at $31.00 by Mizuho


© 2006-2019 Ticker Report